Literature DB >> 8073465

Reduced blood-brain barrier permeability after cardiac arrest by conjugated superoxide dismutase and catalase in piglets.

C L Schleien1, B Eberle, D H Shaffner, R C Koehler, R J Traystman.   

Abstract

BACKGROUND AND
PURPOSE: Cardiac arrest and resuscitation in immature piglets result in a delayed increase in blood-brain barrier permeability. We tested the hypothesis that pretreatment with oxygen radical scavengers reduces postischemic permeability.
METHODS: Permeability was assessed by measuring the plasma-to-brain transfer coefficient of the small amino acid, alpha-aminoisobutyric acid, in 2- to 3-week-old anesthetized piglets. Three groups were studied: (1) a nonischemic time control group (n = 5), (2) an ischemia group (n = 8) pretreated with 5 mL of polyethylene glycol vehicle, and (3) an ischemia group (n = 8) pretreated with polyethylene glycol conjugated to superoxide dismutase (10,000 U/kg) and to catalase (20,000 U/kg). The ischemia protocol consisted of 8 minutes of ventricular fibrillation, 6 minutes of cardiopulmonary resuscitation, defibrillation, and 4 hours of spontaneous circulation.
RESULTS: The mean +/- SEM of the transfer coefficient of alpha-aminoisobutyric acid in cerebrum was (in microL/g per minute): 1.54 +/- 0.37 in the nonischemic group, 2.04 +/- 0.26 in the ischemia group treated with vehicle, and 1.29 +/- 0.25 in the ischemia group treated with oxygen radical scavengers. Postischemic values with scavenger treatment were significantly lower than those with vehicle treatment in cerebrum, cerebellum, medulla and cervical spinal cord.
CONCLUSIONS: Pretreatment with oxygen radical scavengers reduces postischemic blood-brain barrier permeability by a small amino acid. These data are consistent with oxygen radical-mediated dysfunction of cerebral endothelium in a pediatric model of cardiopulmonary resuscitation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8073465     DOI: 10.1161/01.str.25.9.1830

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  7 in total

1.  Polynitroxyl albumin and albumin therapy after pediatric asphyxial cardiac arrest: effects on cerebral blood flow and neurologic outcome.

Authors:  Mioara D Manole; Patrick M Kochanek; Lesley M Foley; T Kevin Hitchens; Hülya Bayır; Henry Alexander; Robert Garman; Li Ma; Carleton J C Hsia; Chien Ho; Robert S B Clark
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-30       Impact factor: 6.200

Review 2.  Targeting the brain: rationalizing the novel methods of drug delivery to the central nervous system.

Authors:  Shailendra Joshi; Eugene Ornstein; Jeffrey N Bruce
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

3.  Blood brain barrier is impermeable to solutes and permeable to water after experimental pediatric cardiac arrest.

Authors:  Erika E Tress; Robert S B Clark; Lesley M Foley; Henry Alexander; Robert W Hickey; Tomas Drabek; Patrick M Kochanek; Mioara D Manole
Journal:  Neurosci Lett       Date:  2014-06-14       Impact factor: 3.046

Review 4.  Drug administration in animal studies of cardiac arrest does not reflect human clinical experience.

Authors:  Joshua C Reynolds; Jon C Rittenberger; James J Menegazzi
Journal:  Resuscitation       Date:  2007-03-13       Impact factor: 5.262

Review 5.  Global cerebral ischemia: synaptic and cognitive dysfunction.

Authors:  Jake T Neumann; Charles H Cohan; Kunjan R Dave; Clinton B Wright; Miguel A Perez-Pinzon
Journal:  Curr Drug Targets       Date:  2013-01-01       Impact factor: 3.465

6.  Early endothelial damage and leukocyte accumulation in piglet brains following cardiac arrest.

Authors:  M J Caceres; C L Schleien; J W Kuluz; B Gelman; W D Dietrich
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

7.  Systemic Administration of Tempol Attenuates the Cardiorespiratory Depressant Effects of Fentanyl.

Authors:  Santhosh Baby; Ryan Gruber; Joseph Discala; Veljko Puskovic; Nijo Jose; Feixiong Cheng; Michael Jenkins; James Seckler; Stephen Lewis
Journal:  Front Pharmacol       Date:  2021-06-23       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.